Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionTwinbeech Capital Lp
Latest Disclosed Ownership9,797 shares
Latest Disclosed Value $ 1,005,858
Twinbeech Capital Lp ownership in ABL / Abbott Laboratories

On May 15, 2026 - Twinbeech Capital Lp filed a 13F-HR form disclosing ownership of 9,797 shares of Abbott Laboratories (DE:ABL) valued at $870,170 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 0 shares of Abbott Laboratories. The current value of the position is $736,930 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 9,797 9,797 1,006 0.1042
2026-02-17 2025-12-31 13F ABBOTT LABS COM 002824100 0 -28,673 -100.00 0 -100.00
2025-11-14 2025-09-30 13F ABBOTT LABS COM 002824100 28,673 28,673 3,840 0.1519
2024-08-14 2024-06-30 13F ABBOTT LABS COM 002824100 0 -352,692 -100.00 0 -100.00
2024-05-15 2024-03-31 13F ABBOTT LABS COM 002824100 352,692 352,692 40,087 0.8272
2023-11-14 2023-09-30 13F ABBOTT LABS COM 002824100 0 -335,680 -100.00 0 -100.00
2023-08-14 2023-06-30 13F ABBOTT LABS COM 002824100 335,680 169,414 101.89 36,596 117.36 0.7225
2023-05-15 2023-03-31 13F ABBOTT LABS COM 002824100 166,266 146,259 731.04 16,836 666.67 0.3409
2023-02-14 2022-12-31 13F ABBOTT LABS COM 002824100 20,007 20,007 2,197 0.0417
2022-05-16 2022-03-31 13F ABBOTT LABS COM 002824100 0 -20,056 -100.00 0 -100.00
2022-02-14 2021-12-31 13F ABBOTT LABS COM 002824100 20,056 8,543 74.20 2,823 107.57 0.1608
2021-11-15 2021-09-30 13F ABBOTT LABS COM 002824100 11,513 11,513 1,360 0.0958
2020-11-16 2020-09-30 13F ABBOTT LABS COM 002824100 0 -63,292 -100.00 0 -100.00
2020-08-14 2020-06-30 13F ABBOTT LABS COM 002824100 63,292 63,292 5,787 1.2684
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.